Focus on Peptide and Oligonucleotide API
Empowering Global Healthcare Innovation
View More
Leading in Peptides API, Advancing in Oligonucleotides API.
Our products demonstrate strong competitiveness and showcase vast market potential.
Core products include Lanreotide Acetate, Semaglutide, Tirzepatide, and Retatrutide.
US FDA Registration No.: 041446
US FDA Registration No.: 043257
US FDA Registration No.: 043251
Three-target GLP-1R/GCGR/GIPR
The world's first long-acting HIV fusion inhibitor. Commercial supply has been achieved.
Dorui is speaking out to obtain the latest technological updates